AlphaVax receives NIAID contract to support development of HIV vaccine.
D016915:AIDS Vaccines / Q000276:immunology*; D005380:Financing, Government; D015658:HIV Infections / Q000517:prevention & control; D006801:Humans; D009316:National Institutes of Health (U.S.); D017149:Private Sector; D013678:Technology, Pharmaceutical; D014481:United States
D016915:AIDS Vaccines